ALX ONCOLOGY HOLDINGS INC.

(ALXO)
  Report
Delayed Nasdaq  -  04:00 2022-08-16 pm EDT
14.62 USD   -3.43%
10:24aALX Oncology's Evorpacept Picked for New Treatment Arm in Breast Cancer Trial
MT
09:55aALX Oncology and Quantum Leap Healthcare Collaborative™ Announce the Selection of Evorpacept in the I-SPY-P1 TRIAL in Combination with Enhertu® in Breast Cancer
PR
08/15ALX ONCOLOGY : Corporate Presentation
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Upcoming event on ALX ONCOLOGY HOLDINGS INC.